Meeting commentary--formulating better medicines for children.
Hempenstall
John
J
Product Development, GlaxoSmithKline, Harlow, United Kingdom.
Tuleu
Catherine
C
D000367:Age Factors; D002648:Child; D004339:Drug Compounding / Q000592:standards; D004345:Drug Industry / Q000458:organization & administration; D064420:Drug-Related Side Effects and Adverse Reactions; D005079:Excipients / Q000737:chemistry*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013649:Taste
D005079:Excipients; D004364:Pharmaceutical Preparations